DocGo (DCGO) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
16 Sep, 2026Business overview and strategy
Leading provider of technology-enabled mobile healthcare, offering services at scale across the US and UK, including care in the home, virtual care, mobile phlebotomy, and medical transportation.
Proprietary technology platform integrates with major EHRs, supports logistics, scheduling, and patient communications, and includes AI-driven solutions for efficiency and quality.
Vertical integration includes clinical practice group, laboratory license, and managed care credentials, creating a defensible competitive moat.
Mission-driven approach focuses on delivering care to any address, improving access for underserved and homebound populations.
Growth strategy leverages long-term customer relationships, payer programs, virtual care management, and M&A to expand services and reach.
Financial performance and key metrics
Q2 2026 total revenue was $73.4M, with a 30.5% adjusted gross margin and an adjusted EBITDA loss of $6.3M.
Mobile health segment revenue reached $21.4M (27.0% margin); medical transportation segment revenue was $52.0M (32.0% margin).
No long-term debt as of Q2 2026, with $25.2M in unrestricted cash; planned assumption of $52M debt for Hicuity Health acquisition.
Record volumes in all major business lines, including 15% growth in US medical transportation and 58% growth in virtual care & lab orders year-over-year.
Over 1.7 million patients assigned for care gap closure since inception, with strong growth in completed visits and virtual care engagements.
Market opportunity and industry trends
Addressable US at-home care market estimated at $230B, with 30% of PCP market expected to shift to nontraditional providers.
Medical transportation market size estimated at $7–$13B.
Chronic disease drives 90% of US healthcare expenditures, creating demand for tailored solutions across the care continuum.
Healthcare delivery is shifting toward integrated, technology-enabled models due to workforce shortages, financial pressures, rising demand, and an aging population.
Latest events from DocGo
- Profitability, tech-driven efficiency, and strategic acquisitions drive growth and margin improvement.DCGO
Morgan Stanley 24th Annual Global Healthcare Conference - Q2 2026 revenue fell 8.7% but core lines grew 19% as net loss widened to $18.0M.DCGO
Q2 2026 - Record growth, board transition, and tech-driven initiatives mark a pivotal year.DCGO
AGM 2026 - Transitioning to proactive, tech-enabled care, the company targets growth and profitability.DCGO
Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Tech-driven healthcare platform posts strong growth, raises guidance, and targets profitability.DCGO
21st Annual Needham Technology, Media, & Consumer Conference - Rapidly scaling mobile healthcare and transport with strong growth, tech integration, and expanding margins.DCGO
Investor presentation - Q1 revenue was $75.6M, net loss widened, but 2026 guidance was raised on strong core growth.DCGO
Q1 2026 - Q3 revenue dropped 26%, but net income and adjusted EBITDA rose, with guidance raised.DCGO
Q3 2024 - Q2 revenue up 31% to $164.9M, net income and margins rose, cash flow guidance increased.DCGO
Q2 2024